Market Closed - Nasdaq Copenhagen 10:59:54 2024-04-24 am EDT 5-day change 1st Jan Change
922 DKK +0.59% Intraday chart for Coloplast A/S +2.40% +19.43%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024. CI
COLOPLAST : Q1 24: Many more positives beyond the margin beat Alphavalue
Nordic Shares Moved Upward Friday; Kongsberg Gruppen Topped Leaders DJ
Global markets live: Tesco, Boeing, Roche, Exxon Mobil, PepsiCo... Our Logo
Transcript : Coloplast A/S, Q1 2024 Earnings Call, Feb 09, 2024
European shares flat as higher yields counter earnings bump RE
European shares inch up on earnings bump, higher yields weigh RE
Coloplast Posts Growth in Fiscal Q1 Net Profit, Revenue MT
Coloplast Launches Peristeen Light for People with Bowel Disorders CI
Coloplast A/S Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Coloplast A/S Reaffirms Earnings Guidance for the Fiscal Year 2023/24 CI
Coloplast Rolls Out New Silicone Foam for Wound Care in US MT
Coloplast A/SLaunches Biatain® Silicone Fit for Pressure Injury Prevention and Wound Management in the US CI
Nordic Stocks Decreased Wednesday; Kone B Posted Biggest Loss DJ
COLOPLAST : EPS cut (2023: -12.9%, 2024: -14.7%) Alphavalue
Coloplast A/S Approves the Distribution of Year-End Dividend CI
COLOPLAST : Q4 23: more misses than hits Alphavalue
Sweden's Bactiguard Hires New CFO MT
Nordic Stocks Decreased Thursday; Okeanis Eco Tankers Took Biggest Hit DJ
Transcript : Coloplast A/S, 2023 Earnings Call, Nov 09, 2023
European shares gain on earnings boost; investors await cues on policy outlook RE
Coloplast to Build EUR100 Million Intermittent Catheter Manufacturing Site in Portugal MT
Coloplast A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023 CI
Coloplast Books Higher FY23 Net Profit; Revenue Jumps MT
Coloplast Announces New Manufacturing Site in Portugal CI
Chart Coloplast A/S
More charts
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
922 DKK
Average target price
917.1 DKK
Spread / Average Target
-0.54%
Consensus
  1. Stock Market
  2. Equities
  3. COLO B Stock
  4. News Coloplast A/S
  5. Coloplast's Fiscal Q1 Profit Declines Amid Higher Expenses